Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Incyte Japan gains approval for Minjuvi with rituximab and lenalidomide to treat relapsed follicular lymphoma

Incyte Japan gains approval for Minjuvi with rituximab and lenalidomide to treat relapsed follicular lymphoma

Dec 22, 2025

Post navigation

Hologic breast cancer study bolsters use of mammogram AI

Boehringer spells out a $448M future for Rectify’s ABC kidney disease program

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: